ResMed Inc. vs Stanley Black & Decker, Inc. — how do they compare? ResMed Inc. trades at $230.05 (market cap $31.89B), while Stanley Black & Decker, Inc. trades at $88.57 (market cap $13.47B). The key difference: ResMed Inc. is far larger — about 2.4× Stanley Black & Decker, Inc.'s market cap, and Stanley Black & Decker, Inc. pays the higher dividend (3.77%). Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and Stanley Black & Decker, Inc. for 62 Days on average.
| RMD | SWK | |
|---|---|---|
Market Cap | $31.89B | $13.47B |
Volume | 618,314 | 2,859,744 |
Sector | Health | Industrials |
52-Week High | $275.96 | $104.00 |
52-Week Low | $182.82 | $62.12 |
Typical Hold Time | 51 Days | 62 Days |
Enterprise Value | $31.24B | $17.63B |
Dividend Yield | 1.16% | 3.77% |
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $226.73, up 0.33% today, with a bullish technical signal from moving averages and a neutral RSI. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15 billion in 2025, with a net income margin of 26.94%, while cash flow from operations reached $1.75 billion. Recent news highlights an upcoming Q1 2027 earnings report and management's focus on 12%-14% EPS growth driven by demand in sleep therapy.
The outlook for RMD is positive, supported by robust fundamentals and analyst consensus, though risks include competitive pressures and ongoing legal investigations. Upside potential exists with a consensus price target of $242.70, representing a 7% increase from current levels, but investors should monitor execution against growth targets and market share dynamics.
Stanley Black & Decker (SWK) trades at $89.17, showing modest daily gains of 0.97%. The stock exhibits bearish technical signals with neutral oscillators, while fundamentals show improving profitability with three consecutive quarterly earnings beats. Recent product launches and margin improvement initiatives support growth prospects, though cash flow trends remain mixed. The company maintains Dividend King status with over 200 years of dividend payments.
SWK presents a balanced opportunity with improving earnings momentum and attractive valuation metrics, though technical weakness and margin pressures warrant caution. Analyst consensus leans neutral with a $93 price target suggesting limited upside. Key risks include execution challenges in margin improvement and competitive pressures in the tools market.
Trailing returns across standard periods
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →